Sanarus Medical develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors.
Description
Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors. It offers Visica treatment system for cryoablation of breast fibroadenomas; Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and ImarC tissue marker system, a line of breast tissue markers that are visible under imaging modalities. The company was founded in 1999 and is headquartered in Pleasanton, California.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Pleasanton, California, United States, North America